Condition: Chronic Rhinosinusitis · Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
This is a multicenter, randomized, continuing, Phase II expansion trial to evaluate the safety, efficacy, and immunogenicity of two doses of TQH2722 in the long-term treatment of severe chronic sinusitis with or without nasal polyps.
This description comes directly from the study's public registry record.
Luo Zhang, Postdoctoral · 13910830399 · dr.luozhang@139.com
Always discuss trial participation with your own doctor first.
| Beijing Tongren Hospital, Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| The First People's Hospital of Foshan | Foshan, Guangdong, China | Not Yet Recruiting |
| The Second People's Hospital of Shenzhen | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Guangxi Medical University Cancer Hospital | Nanning, Guangxi, China | Not Yet Recruiting |
| Hebei Medical University Third Hospital | Shijiazhuang, Hebei, China | Not Yet Recruiting |
| Cangzhou Central Hospital | Cangzhou, Heibei, China | Not Yet Recruiting |
| Henan Provincial People's Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| Union Hospital, Tongji Medical College, Huazhong University of science and technology | Wuhan, Hubei, China | Not Yet Recruiting |
| Renmin Hospital of Wuhan University Hubei General Hospital | Wuhan, Hubei, China | Not Yet Recruiting |
| Loudi Central Hospital | Changsha, Hunan, China | Not Yet Recruiting |
| Baotou Central Hospital | Baotou, Inner Mongolia, China | Not Yet Recruiting |
| Nanjing Drum Tower Hospital | Nanjing, Jiangsu, China | Not Yet Recruiting |
+ 16 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06439381